By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.
Is 6 months of dual antiplatelet therapy (DAPT) therapy noninferior to 12 months, following ST-elevation myocardial infarction (STEMI) with...
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
How often are physicians treating isolated subsegmental pulmonary embolisms?
Do symptomatic venous thromboembolism (VTE) complications improve with posthospitalization thromboprophylaxis using rivaroxaban for an at-risk...
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous...
Latest News for HOSP
How does inferior vena cava (IVC) filter placement affect 30-day mortality in patients with venous thromboembolism (VTE) with increased risk of...
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.